Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Scientists thought they knew what's lurking at the centre of our Galaxy. But they may have been completely wrong this whole time | BBC Sky at Night Magazine